Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vycor Medical (VYCO) Interest Expenses (2016 - 2025)

Vycor Medical has reported Interest Expenses over the past 15 years, most recently at $12570.0 for Q4 2025.

  • Quarterly Interest Expenses changed 0.0% to $12570.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $50852.0 through Dec 2025, down 1.84% year-over-year, with the annual reading at $50283.0 for FY2025, 0.54% up from the prior year.
  • Interest Expenses was $12570.0 for Q4 2025 at Vycor Medical, roughly flat from $12571.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $16470.0 in Q4 2023 and troughed at $368.0 in Q4 2022.
  • The 5-year median for Interest Expenses is $12570.5 (2024), against an average of $10983.6.
  • Year-over-year, Interest Expenses crashed 95.45% in 2022 and then skyrocketed 4375.54% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $8088.0 in 2021, then crashed by 95.45% to $368.0 in 2022, then skyrocketed by 4375.54% to $16470.0 in 2023, then dropped by 23.68% to $12570.0 in 2024, then changed by 0.0% to $12570.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Interest Expenses are $12570.0 (Q4 2025), $12571.0 (Q3 2025), and $12572.0 (Q2 2025).